ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 543 filers reported holding ASTRAZENECA PLC in Q3 2018. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $506,000 | -61.3% | 14,400 | -61.5% | 0.40% | -62.0% |
| Q1 2018 | $1,308,000 | +0.8% | 37,400 | 0.0% | 1.06% | +13.1% |
| Q4 2017 | $1,298,000 | +2.4% | 37,400 | 0.0% | 0.94% | -3.0% |
| Q3 2017 | $1,267,000 | -0.6% | 37,400 | 0.0% | 0.97% | -6.9% |
| Q2 2017 | $1,275,000 | -4.1% | 37,400 | -12.4% | 1.04% | -4.8% |
| Q1 2017 | $1,330,000 | +14.0% | 42,700 | 0.0% | 1.09% | +31.4% |
| Q4 2016 | $1,167,000 | -16.8% | 42,700 | 0.0% | 0.83% | -11.8% |
| Q3 2016 | $1,403,000 | +8.8% | 42,700 | 0.0% | 0.94% | +7.2% |
| Q2 2016 | $1,289,000 | +7.2% | 42,700 | 0.0% | 0.88% | +12.3% |
| Q1 2016 | $1,202,000 | +378.9% | 42,700 | +477.0% | 0.78% | +371.7% |
| Q4 2015 | $251,000 | +6.8% | 7,400 | 0.0% | 0.17% | 0.0% |
| Q3 2015 | $235,000 | -0.4% | 7,400 | +100.0% | 0.17% | +2.5% |
| Q2 2015 | $236,000 | -6.7% | 3,700 | 0.0% | 0.16% | -4.1% |
| Q1 2015 | $253,000 | – | 3,700 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |